Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,276 | 33,032 | 35,493 | 26,498 | 28,109 |
| Marketable Securities | 135,906 | 146,766 | 165,879 | 191,707 | 208,480 |
| Receivables | N/A | N/A | N/A | 7,000 | N/A |
| Other current assets | 0 | 0 | 0 | 935 | 933 |
| TOTAL | $167,617 | $185,613 | $206,950 | $230,516 | $243,504 |
| Non-Current Assets | |||||
| PPE Net | 3,391 | 3,652 | 3,912 | 4,403 | 4,666 |
| Other Non-Current Assets | 8,913 | 9,865 | 10,373 | 14,407 | 15,209 |
| TOTAL | $12,304 | $13,517 | $14,285 | $18,810 | $19,875 |
| Total Assets | $179,921 | $199,130 | $221,235 | $249,326 | $263,379 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,609 | 1,304 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,263 | 5,059 | 8,251 | 3,120 | 2,492 |
| Accrued Expenses | 9,363 | 6,664 | 6,481 | 10,657 | 8,463 |
| TOTAL | $17,495 | $16,161 | $17,744 | $16,672 | $13,737 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,589 | 8,829 | 10,069 | 10,010 | 9,952 |
| Other Non-Current Liabilities | 4,152 | 5,019 | 5,852 | 6,650 | 7,413 |
| TOTAL | $11,741 | $13,848 | $15,921 | $16,660 | $17,365 |
| Total Liabilities | $29,236 | $30,009 | $33,665 | $33,332 | $31,102 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,296 | 7,280 | 7,280 | 7,269 | 7,269 |
| Common Shares | 73 | 73 | 7 | 73 | 73 |
| Retained earnings | -393,968 | -372,421 | -350,763 | -318,503 | -295,400 |
| Other shareholders' equity | -385 | -355 | -130 | -687 | -830 |
| TOTAL | $150,685 | $169,121 | $187,570 | $215,994 | $232,277 |
| Total Liabilities And Equity | $179,921 | $199,130 | $221,235 | $249,326 | $263,379 |